[The controversy surrounding high-dose chemotherapy (HDC) for breast cancer seems to have given place to skepticism about its efficacy, regardless of regimen or schedule, for any subset of patients with high-risk primary breast cancer (HRPBC) or metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE